BOSTON SCIENTIFIC CORP (BSX)
NYSE • Healthcare
Last close at July 2, 2026 at 20:00 UTC
Fundamentals Charts
About BOSTON SCIENTIFIC CORP
Boston Scientific Corporation designs, manufactures, and commercializes medical devices for cardiovascular, rhythm-management, neurostimulation, and procedural care markets. Listed on the NYSE as BSX, the company operates in healthcare as a medical-device maker and generated $20.1 billion in revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
BOSTON SCIENTIFIC CORP's Technical Indicators Summary
BSX is near $45 and exhibits a bearish tilt underpinned by a strong directional reading and heavy negative volume, while momentum indicators remain subdued. Short-term averages are close to the market, but medium- and long-term SMAs lie well above the price, indicating the dominant downtrend, and ATR shows moderate intraday range. Classic pivot levels are below the market, offering nearby reference. Technical takeaway: Sell.
| Indicator | Value |
|---|---|
RSI (14) | 40.36 |
Stochastic %K (14, 3, 3) | 23.73 |
CCI (20) | -46.84 |
WPR (14) | -47.93 |
Momentum (10) | 0.19 |
MFI | 31.33 |
MACD Level (12, 26) | -2.36 |
Bollinger Bands | $41.83 - $50.03 |
ATR (14) | $1.62 (3.59%) |
ADX (14) | 39.16 |
OBV | -502,383,816 |
Classic Pivot Point | $43.18 |
Fibonacci Pivot Point | $43.18 |
Simple Moving Averages | $44.25 - $78.43(5 indicators) |
Exponential Moving Averages | $44.50 - $75.46(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
Despite intraday swings, BSX preserved the bulk of its 4.75% gap versus yesterday. By the close, sector strength was clear, with a 2.65% gain underpinning risk appetite. BSX rises as Neuromodulation and Interventional Oncology show momentum, with Penumbra seen as a key longer-run growth driver.
Trading Volume
0
vs S&P 500 Today
Outperforming Market
+2.38%
52-Week Position
Near lows
4.2%
Updated: July 2, 2026 at 20:15 UTC